CLASS II ONGOING Device recall · Reported 12 Aug 2026 · FDA Enforcement Report

5-Plasma Bivalirudin AMR Verification Kit recalled by Aniara Diagnostica

Aniara Diagnostica is recalling 5-Plasma Bivalirudin AMR Verification Kit, distributed nationwide in the US. The recall was initiated on 1 Jul 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 05070002420378, Lot Number: KE132603
Quantity recalled4 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2894-2026
FDA event ID
99344
Recalling firm
Aniara Diagnostica, West Chester, OH
Classification
Class II
Status
Ongoing
Recall initiated
1 Jul 2026
FDA classified
5 Aug 2026
Reported
12 Aug 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

1 Jul 2026Recall initiated by company
5 Aug 2026Classified by FDA+35 days
12 Aug 2026Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Stability issues with the reconstituted lyophilized human plasma and bivalirudin matrix have been identified. These stability issues lead to a degradation of measurable bivalirudin in the controls, calibrators, and linearity values.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

5-PLASMA Bivalirudin AMR Verification Kit, Model Number 5D-45905

Where it was distributed

US Nationwide distribution in the states of IL, NC, TN.

Nationwide IllinoisNorth CarolinaTennessee

Questions about this recall

Why was it recalled?

Stability issues with the reconstituted lyophilized human plasma and bivalirudin matrix have been identified. These stability issues lead to a degradation of measurable bivalirudin in the controls, calibrators, and linearity values.

Which lots are affected?

UDI-DI: 05070002420378, Lot Number: KE132603

Where was it sold?

US Nationwide distribution in the states of IL, NC, TN.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 99344

More recalls from Aniara Diagnostica

All 11

Other Other Medical Devices recalls

All 13,908